Ozurdex 0.7 MG implants

Ended Awarded

Contract number
SPE2DB24FDG75
Awardee
Awarding agency
Obligated
$3,005

Award facts

Contract value 100% obligated
$3,004.53 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of OZURDEX 0.7 MG IMPLANTS. The contract has a potential value of $3,004.53 and a completion date of March 14, 2024. This delivery order contract is part of a larger indefinite delivery contract (Contract #4600082013) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which has a ceiling value of up to $4,999,999 through the end of 2025. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DB24FDG75?

SPE2DB24FDG75 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 22, 2024.

How much is contract SPE2DB24FDG75 worth?

The government has obligated $3,005 on SPE2DB24FDG75.

Is contract SPE2DB24FDG75 an order under another contract?

Yes. SPE2DB24FDG75 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.

Was contract SPE2DB24FDG75 competed?

The extent of competition for SPE2DB24FDG75 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login